-
The Global Fund’s 2023 Results Report released today shows a remarkable acceleration of programmatic results in the fight against HIV, TB and malaria, after losses from the COVID-19 pandemic. However, multiple challenges, including climate change and...
-
Through its competitive tenders, the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), together with its partners and generic pharmaceutical manufacturers, will be able to offer tenofovir disoproxil fumarate, lamivudine and dolut...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) is launching a new Revolving Facility to negotiate improved supply terms for global health products for the countries it supports. This financial mechanism uses advanced market...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and Unitaid are partnering to accelerate the manufacturing of health products in Africa, with HIV rapid diagnostic...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria applauds GSK and ViiV Healthcare’s combined commitment of US$7.5 million over three years for the Gender Equality Fund, which will help accelerate progress towards gender equality through commun...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria and the Agence française de développement/Expertise France (AFD/EF) have announced they are renewing and strengthening their program of technical assistance for Chad; it covers the period from 2...
-
Ambassador Dr. John N. Nkengasong, U.S. Global AIDS Coordinator and Special Representative for Global Health Diplomacy, visited Maputo June 14-16. Ambassador Nkengasong was accompanied by UNAIDS Executive Director Winnie Byanyima, who leads the Unite...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), the Joint United Nations Programme on HIV/AIDS (UNAIDS), and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) are deeply concerned about the harmful impact of the ...
-
The Laboratory Systems Integration Fund – supported by The Rockefeller Foundation, the Abbott Fund and IQVIA through (RED), and matched by the Global Fund – is supporting an investment of US$54 million toward the development of stronger and better co...
-
Oxygen, a lifesaving medicine to treat acute respiratory illnesses like COVID-19 and pneumonia, is essential for surgery, trauma, emergency and critical care, and treating older persons, pregnant women and newborns. Medical oxygen is also proving to ...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria has committed nearly US$1 million in emergency funding to Mozambique to mitigate the impact of the floods and Cyclone Freddy on malaria programs in the southern provinces of the country.
-
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria held its 49th meeting on 10 and 11 May 2023 in Ha Noi, Viet Nam, the first to take place in the Western Pacific region since 2007.
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria announced its Board has selected Lady Roslyn Morauta as Chair and Bience Gawanas as Vice-Chair, bringing two women with an exceptional level of leadership and international expertise to the gove...
-
Kenyan President William Ruto inaugurated the procurement and distribution of US$41.7 million worth of oxygen products throughout the country this week, with funding from the Global Fund COVID-19 Response Mechanism (C19RM) in partnership with the gov...
-
In a remarkable public health achievement, Azerbaijan and Tajikistan were today certified malaria-free by the World Health Organization (WHO). The certification is granted when a country proves that it has interrupted indigenous transmission of the d...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria and Unitaid welcome WHO’s recommendation for the widespread use of a new class of mosquito net that uses two active ingredients – pyrethroid and chlorfenapyr. The new net has demonstrated approx...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), the United States Agency for International Development (USAID) and the Stop TB Partnership announced a new collaboration today with Molbio Diagnostics that significantly reduc...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved an additional US$10.32 million in emergency funding to maintain essential HIV and tuberculosis (TB) services in Ukraine as this week marks one year since Russia launched a full-scal...
-
Since December 2022, the Global Fund has awarded US$547 million in additional funding to 40 countries through its COVID-19 Response Mechanism (C19RM) and has now initiated the process to award a further US$320 million, making a total of approximately...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria is pleased to announce that the pledge made by Vietnamese philanthropist Ms. Le Nu Thuy Duong will support innovative TB programs throughout Viet Nam. Her US$3 million pledge was further bolster...